Skip to content
Governance Register
Sign inFind yourself
Find yourselfSign in
Search How it works For organisations For professionals

Edition

United Kingdom (current)IrelandUnited StatesNew ZealandCanadaAustraliaScotlandNorthern Ireland

Company

Viridian Pharma Limited

Viridian Pharma Limited is an active UK company (number 04398894), incorporated 2002, with 4 current directors including Alexander Mehrai and Foucauld Ruyant. Source: Companies House, updated 4th October 2026.

How am I connected?
More
View network map Report an issue

Official record Companies House · updated 4th October 2026 · Sources

Network

The large node is Viridian Pharma Limited. Red nodes are organisations, white nodes are people. Sign in free to explore further.

Who leads it

Previous officers 13

  1. Andrea Bovolenta 2024-2024 Director View profile
  2. Jean Bernard Claude Monin 2022-2023 Director View profile
  3. Bertrand Deluard 2019-2022 Director View profile
  4. Emmanuel Schmidt 2019-2022 Director View profile
  5. Roseline Georgette Joannesse 2017-2019 Director View profile
  6. Jason Grover 2016-2017 Director View profile
  7. Michael Christopher James Harris 2016-2019 Director View profile
  8. Michael Leslie Clark 2016-2017 Director View profile
  9. Timothy Joseph Rockley 2002-2016 Director View profile
  10. Julian Craig Smith 2002-2016 Director View profile
  11. David Pow 2002-2002 Director View profile
  12. Gillian Dawn Smith 2002-2016 Secretary View profile
  13. Michael George Lanning 2002-2016 Secretary View profile

Directors and secretaries as filed at Companies House.

Do you help lead this organisation? Set up its network · How it works

About

Incorporated
20/03/2002

Ownership

Owned by (2) iOwned byIndividuals and companies registered as having significant control over this company, from the Companies House PSC (persons with significant control) register. People whose ownership could not be confirmed to one individual are not listed as confirmed owners.

  • Orphea Limited
    75-100% shares, 75-100% voting, appoints directors · notified 2023-08-30
  • Macarthys Laboratories Limited ceased 2023-08-30
    75-100% shares, 75-100% voting, appoints directors, significant influence · notified 2016-07-01

Group

  1. Viridian Pharma Limited is controlled by Orphea Limited
    Evidence
    active 75-100% shares, 75-100% voting, appoints directors · notified 2023-08-30 · source: Companies House PSC register

Ultimately controlled by Orphea Limited.

10 other companies in this group

Ownership paths are calculated from Companies House persons-with-significant-control filings. Each step shows the filed nature of control and dates; a step marked "ceased" is historical, not current.

Board analysis

Board DNA

How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.

4 directors on the board

2.2y median 2.4y
average tenure
3.5y
longest tenure
0
directors past 6 years

First-time vs portfolio directors

Portfolio (4)

0
also govern a charity
0
left in the last 12 months

Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.

Manufacturing 8Retail and trade 6Finance 3Professional services 2

The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.

Sources

Official record from Companies House. Governance Register calculates the connections.

Record details
Company number
04398894
Status
Active
Type
Private Limited Company
Edition
Register edition compiled 4th October 2026
Labels
Official record from Companies House · Calculated derived by Governance Register.

Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data